LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Operating cash flow, 2025
- $49M
- YoY, 2025
- −49.1%
- 5-year CAGR
- −2.0%
- 10-year CAGR
- +1.7%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $49M | −49.1% |
| 2024 | $97M | +95.8% |
| 2023 | $50M | −64.0% |
| 2022 | $138M | +74.9% |
| 2021 | $79M | +44.4% |
| 2020 | $55M | — |
| 2019 | −$29M | — |
| 2018 | $194M | +119.1% |
| 2017 | $89M | +45.8% |
| 2016 | $61M | +45.5% |
| 2015 | $42M | +102.9% |
| 2014 | $21M | −0.6% |
| 2013 | $21M | +12,750.9% |
| 2012 | $161K | — |
| 2011 | −$1.2M | — |
| 2010 | −$27M | — |
| 2009 | −$34M | — |